Neuphoria Therapeutics Inc. (NEUP) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$15.6M

Net Income/Loss (FY2025)

-$369.6K

Total Assets (FY2025)

$28.6M

Total Equity (FY2025)

$19.0M

Cash Flows from Operating Activities (FY2025)

$77.2K

Source: Neuphoria Therapeutics Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.